DTIL
Price
$4.57
Change
-$0.24 (-4.99%)
Updated
Aug 7 closing price
Capitalization
50.67M
ORMP
Price
$2.08
Change
-$0.01 (-0.48%)
Updated
Aug 7 closing price
Capitalization
84.96M
5 days until earnings call
Interact to see
Advertisement

DTIL vs ORMP

Header iconDTIL vs ORMP Comparison
Open Charts DTIL vs ORMPBanner chart's image
Precision BioSciences
Price$4.57
Change-$0.24 (-4.99%)
Volume$87.1K
Capitalization50.67M
Oramed Pharmaceuticals
Price$2.08
Change-$0.01 (-0.48%)
Volume$99.88K
Capitalization84.96M
DTIL vs ORMP Comparison Chart in %
Loading...
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DTIL vs. ORMP commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTIL is a Hold and ORMP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (DTIL: $4.57 vs. ORMP: $2.08)
Brand notoriety: DTIL and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DTIL: 26% vs. ORMP: 135%
Market capitalization -- DTIL: $50.67M vs. ORMP: $84.96M
DTIL [@Biotechnology] is valued at $50.67M. ORMP’s [@Biotechnology] market capitalization is $84.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DTIL’s FA Score shows that 1 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • DTIL’s FA Score: 1 green, 4 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, both DTIL and ORMP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DTIL’s TA Score shows that 3 TA indicator(s) are bullish while ORMP’s TA Score has 3 bullish TA indicator(s).

  • DTIL’s TA Score: 3 bullish, 6 bearish.
  • ORMP’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both DTIL and ORMP are a bad buy in the short-term.

Price Growth

DTIL (@Biotechnology) experienced а -3.79% price change this week, while ORMP (@Biotechnology) price change was -3.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

ORMP is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($85M) has a higher market cap than DTIL($50.7M). ORMP has higher P/E ratio than DTIL: ORMP (20.91) vs DTIL (4.53). DTIL YTD gains are higher at: 19.948 vs. ORMP (-14.050). DTIL has higher annual earnings (EBITDA): -16.57M vs. ORMP (-21.53M). ORMP has more cash in the bank: 131M vs. DTIL (77.2M). ORMP has less debt than DTIL: ORMP (301K) vs DTIL (29.7M). DTIL has higher revenues than ORMP: DTIL (51.1M) vs ORMP (2M).
DTILORMPDTIL / ORMP
Capitalization50.7M85M60%
EBITDA-16.57M-21.53M77%
Gain YTD19.948-14.050-142%
P/E Ratio4.5320.9122%
Revenue51.1M2M2,555%
Total Cash77.2M131M59%
Total Debt29.7M301K9,867%
FUNDAMENTALS RATINGS
DTIL vs ORMP: Fundamental Ratings
DTIL
ORMP
OUTLOOK RATING
1..100
8662
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
5976
P/E GROWTH RATING
1..100
10049
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DTIL's Valuation (30) in the Biotechnology industry is in the same range as ORMP (56) in the Pharmaceuticals Other industry. This means that DTIL’s stock grew similarly to ORMP’s over the last 12 months.

DTIL's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that DTIL’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's SMR Rating (95) in the Pharmaceuticals Other industry is in the same range as DTIL (97) in the Biotechnology industry. This means that ORMP’s stock grew similarly to DTIL’s over the last 12 months.

DTIL's Price Growth Rating (59) in the Biotechnology industry is in the same range as ORMP (76) in the Pharmaceuticals Other industry. This means that DTIL’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's P/E Growth Rating (49) in the Pharmaceuticals Other industry is somewhat better than the same rating for DTIL (100) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than DTIL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DTILORMP
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 17 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLP0.680.02
+3.36%
Hongli Group
SG12.660.34
+2.76%
Sweetgreen
KPCUF4.76N/A
N/A
KASIKORNBANK Public Co. Ltd.
PSTL14.61-0.02
-0.14%
Postal Realty Trust
BRX26.11-0.41
-1.55%
Brixmor Property Group